CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
1 Year Est. Return
+39.18%
AUM
$19.3B
AUM Growth
-$803M
(-4%)
Holding
738
Top Buys
| 1 | +$78.3M | |
| 2 | +$57M | |
| 3 | +$48M | |
| 4 |
Alibaba
BABA
|
+$43.4M |
| 5 |
Apple
AAPL
|
+$39M |
Top Sells
| 1 | +$87.5M | |
| 2 | +$45.5M | |
| 3 | +$44.5M | |
| 4 |
JPMorgan Chase
JPM
|
+$44.3M |
| 5 |
IQVIA
IQV
|
+$43M |
Sector Composition
| 1 | Technology | 32.73% |
| 2 | Healthcare | 27.11% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Vera Therapeutics
VERA
$2.22B
| $19.1M | 0.1% |
475,335
+25,781
|
|
||
202
Texas Instruments
TXN
$280B
| $18.9M | 0.1% |
97,367
+3,023
|
|
||
203
Apogee Therapeutics
APGE
$6.23B
| $18.8M | 0.1% |
223,541
+32,223
|
|
||
204
Jackson Financial
JXN
$7.23B
| $18.8M | 0.1% |
177,950
+42,607
|
|
||
205
Northern Trust
NTRS
$30.9B
| $18.6M | 0.1% |
132,919
+74,196
|
|
||
206
Vaxcyte
PCVX
$6.81B
| $18.3M | 0.1% |
+315,022
|
|
||
207
Newmont
NEM
$115B
| $18.2M | 0.09% |
168,137
+15,201
|
|
||
208
Fortive
FTV
$18.5B
| $18.1M | 0.09% |
327,358
+262,471
|
|
||
209
Dianthus Therapeutics
DNTH
$4.52B
| $17.9M | 0.09% |
213,522
-97,628
|
|
||
210
Fidelity National Information Services
FIS
$20.9B
| $17.6M | 0.09% |
375,784
+321,624
|
|
||
211
Grupo Cibest SA
CIB
$17.2B
| $17.5M | 0.09% |
240,556
-249,900
|
|
||
212
Natera
NTRA
$30.1B
| $17.1M | 0.09% |
85,677
-13,469
|
|
||
213
Arcus Biosciences
RCUS
$3.08B
| $17.1M | 0.09% |
790,613
|
|
||
214
Immunovant
IMVT
$6.32B
| $16.9M | 0.09% |
680,372
|
|
||
215
Arista Networks
ANET
$222B
| $16.9M | 0.09% |
137,440
+19,505
|
|
||
216
Kymera Therapeutics
KYMR
$6.01B
| $16.8M | 0.09% |
201,672
|
|
||
217
AT&T
T
$164B
| $16.8M | 0.09% |
579,088
+20,075
|
|
||
218
Crown Holdings
CCK
$10.6B
| $16.7M | 0.09% |
166,333
-61,874
|
|
||
219
Magna International
MGA
$18.7B
| $16.5M | 0.09% |
297,267
+21,630
|
|
||
220
Stoke Therapeutics
STOK
$1.8B
| $16.3M | 0.08% |
502,020
+55,330
|
|
||
221
Chemed
CHE
$5.61B
| $16.3M | 0.08% |
43,242
-12,989
|
|
||
222
Target
TGT
$56.7B
| $16.2M | 0.08% |
133,740
-270,809
|
|
||
223
Intel
INTC
$568B
| $16M | 0.08% |
363,368
+9,948
|
|
||
224
Sociedad Química y Minera de Chile
SQM
$22.8B
| $16M | 0.08% |
197,600
-59,000
|
|
||
225
Transmedics
TMDX
$2.35B
| $15.8M | 0.08% |
158,766
+49,580
|
|